Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan
about
Tumor necrosis factor production in patients with leprosyStructural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chainsLipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. Role of the Src homology 2 containing tyrosine phosphatase 1Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence.Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions.Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells.Mycobacterial lipoarabinomannan induces nitric oxide and tumor necrosis factor alpha production in a macrophage cell line: down regulation by taurine chloramineSelective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis.Effects of Mycobacterium tuberculosis on the bioelectric properties of the alveolar epithelium.Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV.Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidaseBacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesisEffects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice.CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein.Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis.The protective role of antibody responses during Mycobacterium tuberculosis infection.A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.Lipoarabinomannan-induced cell signaling involves ceramide and mitogen-activated protein kinase.Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages.Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism.Novel prenyl-linked benzophenone substrate analogues of mycobacterial mannosyltransferases.Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG.
P2860
Q24650697-C50E68E8-634D-4564-8357-5DC7C18329F3Q28204422-E9D28D88-3A7D-4FA1-8E60-B0A907A4FB0FQ28258010-601E72DE-73ED-4437-9012-FB124183A0BBQ33610521-024F18A4-4CAE-43F5-A375-2BA61B068A97Q33750245-4F7B881D-762A-43C3-8F0B-5B33F46B8547Q33751770-C72E00AA-AE8C-4C10-8BC9-6F568CF52713Q33899146-783968CD-BB9F-4F1A-8FF6-83E9965E56BAQ34334259-C44526B0-3176-4242-A8BC-9083ACE116C4Q34374228-36D75860-4440-4C4A-AB6B-42AF0B592290Q34542811-2B01C28D-EE9F-4BD3-8D04-65E78EF597AEQ35465818-076C667E-5BF1-41AF-A9D5-F0BC726550B9Q35567493-EC7BC731-F231-4FE6-A436-38BB3C31860BQ35928399-62A1A600-5F0D-4573-9439-7D1A341206EDQ36369581-C6E17847-0680-4D6E-8250-B6E14876A624Q36671660-05FB3DF7-4AE2-4320-A425-3D53BB0940BFQ36952833-D5E12B86-9A4D-4749-9447-7A5FC806B7F8Q37073534-99D63C6F-1111-4878-996A-DFB624B78444Q37521603-A0F4183D-6870-4DF9-B45E-582BE7B7A838Q37552026-6F8D5380-AF89-42DC-8BBD-6A330373C2C0Q38336530-A74FEBBB-9CA1-4134-B30D-4AAD9D3EA3E9Q39662497-E4E416BA-23C9-4A46-A7D4-543A479BB7DFQ39822031-7C9C730B-C9D2-4D3C-9A4A-4AB05B3A85EBQ40163062-01595C14-6C38-4446-8282-5C87B8B75B40Q42253910-90041ABA-4E1E-4119-9B70-799E8C94D26AQ44064840-5FCEC5F0-F755-4DE7-8874-579AC547A03E
P2860
Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@ast
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@en
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@nl
type
label
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@ast
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@en
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@nl
prefLabel
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@ast
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@en
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@nl
P2860
P1476
Inhibition of interferon-gamma ...... treated with lipoarabinomannan
@en
P2093
J L Krahenbuhl
P2860
P356
10.1111/J.1365-2249.1990.TB06454.X
P407
P577
1990-04-01T00:00:00Z